Every single member of the board of directors at 23andMe has resigned, leaving the embattled CEO, Anne Wojcicki, to search for an entirely new board. The resignations come after months of turmoil at the company, which has faced criticism for its privacy practices and the accuracy of its genetic tests.
Every single member of the board of directors at 23andMe has resigned, leaving the embattled CEO, Anne Wojcicki, to search for an entirely new board. The resignations come after months of turmoil at the company, which has faced criticism for its privacy practices and the accuracy of its genetic tests.
The board members who resigned include:
DNA Tester 23andMe Board Members Resign En Masse
* Susan Desmond-Hellmann, former chancellor of the University of California, San Francisco
* Robert Langer, a professor at the Massachusetts Institute of Technology
* Stacey Snider, former CEO of DreamWorks Animation
* Christiana Figueres, a former executive secretary of the United Nations Framework Convention on Climate Change
* David Baltimore, a Nobel laureate in medicine
* Eric Lander, a geneticist and former director of the Broad Institute
In a statement, the board members said they were "deeply concerned" about the company's "current trajectory" and "lack of progress" in addressing the concerns that have been raised.
"We believe that the company needs a new board of directors with the experience and expertise to guide it through this challenging time," the board members said.
Wojcicki said in a statement that she "respects" the board members' decision and that she is "committed to working with the new board to address the challenges facing the company."
The resignations come at a time when 23andMe is facing a number of challenges. The company has been criticized for its privacy practices, which have been accused of allowing law enforcement to access users' genetic data without their consent. The company has also faced criticism for the accuracy of its genetic tests, which have been shown to be less accurate than tests from other companies.
The resignations are a major blow to 23andMe, which is one of the leading companies in the field of genetic testing. The company has raised more than $1 billion in funding and has more than 10 million customers.
It is unclear what the future holds for 23andMe. The company is now without a board of directors, and it is unclear who will replace the outgoing board members. The company is also facing a number of legal challenges, which could further damage its reputation and its business.
The resignations of the board members are a major development in the ongoing saga of 23andMe. The company is now at a crossroads, and it is unclear what the future holds.
